(Q86228969)
Statements
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus (English)
John P Bilezikian
Robert G Josse
E Michael Lewiecki
Colin G Miller
Margaret Wooddell
Allison R Northcutt
Barbara G Kravitz
Gitanjali Paul
Alexander R Cobitz
Antonio J Nino
Lorraine A Fitzpatrick
28 February 2013